LOXL2 and idiopathic pulmonary fibrosis: All together, these in vitro data suggest that targeting LOXL2 in both normal and IPF primary lung fibroblasts did not alter myofibroblast differentiation or the invasive properties of these cells in a well-established scratch wound invasion assay.